Document Detail


CTLA-4 regulates induction of anergy in vivo.
MedLine Citation:
PMID:  11239447     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The requirement for CTLA-4 during the induction of peripheral T cell tolerance in vivo was investigated using naive TCR transgenic T cells lacking CTLA-4. CTLA-4(-/-) T cells are resistant to tolerance induction, as demonstrated by their proliferative responses, IL-2 production, and progression into the cell cycle. Following exposure to a tolerogenic stimulus in vivo and restimulation in vitro, wild-type T cells are blocked at the late G1 to S restriction point of the cell cycle. In contrast, CTLA-4(-/-) T cells enter into the S phase of the cell cycle, as shown by downregulation of p27(kip1), elevated cdk2 kinase activity, and Rb hyperphosphorylation. Thus, CTLA-4 has an essential role in determining the outcome of T cell encounter with a tolerogenic stimulus.
Authors:
R J Greenwald; V A Boussiotis; R B Lorsbach; A K Abbas; A H Sharpe
Related Documents :
1575717 - Regulation of meiotic maturation in the mammalian oocyte: interplay between exogenous c...
14997017 - Beta-amyloid-activated cell cycle in sh-sy5y neuroblastoma cells: correlation with the ...
8321217 - Cell cycle regulation of the c-myc transcriptional activation domain.
18942077 - Characterization of an alternatively spliced gadd45alpha, gadd45alpha1 isoform, in arse...
11513857 - The protonophore cccp induces mitochondrial permeability transition without cytochrome ...
2900117 - The intestinal epithelial cells of ground squirrel (citellus undulatus) accumulate at g...
Publication Detail:
Type:  In Vitro; Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Immunity     Volume:  14     ISSN:  1074-7613     ISO Abbreviation:  Immunity     Publication Date:  2001 Feb 
Date Detail:
Created Date:  2001-03-12     Completed Date:  2001-04-12     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  9432918     Medline TA:  Immunity     Country:  United States    
Other Details:
Languages:  eng     Pagination:  145-55     Citation Subset:  IM    
Affiliation:
Immunology Research Division, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antigens, CD
Antigens, Differentiation / genetics,  immunology*
Apoptosis
Cell Cycle
Clonal Anergy / immunology*
Cytokines / biosynthesis
DNA-Binding Proteins
Immune Tolerance
Immunoconjugates*
Interleukin-2 / biosynthesis
Lymphocyte Activation
Mice
Mice, Inbred BALB C
Mice, Knockout
Mice, Transgenic
T-Lymphocytes / cytology,  immunology*,  metabolism
Grant Support
ID/Acronym/Agency:
AI35297/AI/NIAID NIH HHS; AI40614/AI/NIAID NIH HHS; AI41584/AI/NIAID NIH HHS; AI43552/AI/NIAID NIH HHS; F32AI10415/AI/NIAID NIH HHS; T32HL07627/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Antigens, CD; 0/Antigens, Differentiation; 0/Cytokines; 0/DNA-Binding Proteins; 0/Immunoconjugates; 0/Interleukin-2; 0/Rag2 protein, mouse; 0/V(D)J recombination activating protein 2; 0/abatacept; 0/cytotoxic T-lymphocyte antigen 4

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Increased TCR avidity after T cell activation: a mechanism for sensing low-density antigen.
Next Document:  Identification and characterization of a novel OCA-B isoform. implications for a role in B cell sign...